Literature DB >> 2651831

Type II collagen distribution in the ear of the developing chick embryo.

T Ishibe1, I S Choe, T J Yoo.   

Abstract

The localization of type II collagen was immunohistochemically studied in the developing chick ear using monoclonal antibodies. Type II collagen appeared under the basal lamina of the otocyst from developmental stages 14 to 16. In the otic capsule, endolymphatic duct, and semicircular canal membrane, type II collagen appeared in stage 23 or 24. From stages 28 to 29, type II collagen appeared in the primitive columella, endolymphatic sac, and fibrocartilaginous plate. Type II collagen was first observed in the crista ampullaris, basilar membrane, macula sacculi, and utriculi in stages 30 and 31. Type II collagen was not detected in the endolymphatic sac beyond developmental stage 37 and the amount of type II collagen in the otic capsule and columella decreased after stage 40. The wide distribution of type II collagen in the inner ear throughout the development of the chick embryo suggests that this collagen may act as a basic structural component of the ear.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2651831     DOI: 10.1288/00005537-198905000-00015

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  4 in total

1.  Electron-microscopic localization of type II, IX, and V collagen in the organ of Corti of the gerbil.

Authors:  N B Slepecky; J E Savage; L K Cefaratti; T J Yoo
Journal:  Cell Tissue Res       Date:  1992-03       Impact factor: 5.249

2.  Molecular markers for cell types of the inner ear and candidate genes for hearing disorders.

Authors:  S Heller; C A Sheane; Z Javed; A J Hudspeth
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-15       Impact factor: 11.205

Review 3.  Biological and clinical aspects of autoimmune inner ear disease.

Authors:  A J Griffith
Journal:  Yale J Biol Med       Date:  1992 Jan-Feb

4.  Expression and function of scleraxis in the developing auditory system.

Authors:  Zoe F Mann; Weise Chang; Kyu Yup Lee; Kelly A King; Matthew W Kelley
Journal:  PLoS One       Date:  2013-09-13       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.